Headquarters: San Francisco Bay Area, CA
Sector: Healthtech, Bioelectronic Medicine
Stage: Commercial
Tivic Health Systems, Inc. is a commercial-stage bioelectronic medicine company focused on treating diseases and conditions by modulating the electrical signals carried along various nerve pathways. We focus on non-invasive products that offer consumers choice in the treatment of inflammation and related conditions.
Our first FDA-approved product, ClearUP® Sinus Pain Relief (“ClearUP”), is a patented handheld device that uses gentle pulsed electron waves to relieve symptoms of sinus and nasal inflammation, nasal allergies, sinus infections, chronic sinusitis, cold and flu.
Roughly 200 million people in the U.S. are impacted by these conditions, representing a potential $8 billion U.S. market.
ClearUP offers a convenient, non-drug alternative for sinus health and is available on Amazon, Best Buy, Walgreens, Walmart and other major e-commerce websites.
ClearUP is built on our non-invasive bioelectronic platform, combining an ergonomic form factor, programmable hardware and patented algorithms that personalize and optimize treatment. This platform is covered by 4 issued U.S. patents. Additionally, 18 patents are pending.
We continue to conduct research to apply this platform to deliver evidence-based bioelectronic alternatives for additional diseases and conditions.
McKinsey & Company estimates that bioelectronic medicine “represents a multibillion dollar opportunity even with modest penetration.”
Stay in the know with all things Tivic.